EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Triple therapy disrupts gut microbiota more severely than quadruple therapy in children with Helicobacter pylori infection

Mei Wang, Ying Su, Xiaodong Wang, Jialing Li, Junhong Chen, Jingfang Chen

Journal of Applied Microbiology · 2025

DOI: 10.1093/jambio/lxaf133 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Applied Microbiology, 2025. Verfasst von Mei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of gastroenterology, Children's Hospital of Fudan University (Xiamen Branch), Xiamen Children's Hospital, Xiamen 361006, China. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Gastrointestinal Microbiome, Anti-Bacterial Agents. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xiamen medical and health guidance, Xiamen Children's Hospital Gastroenterology Clinical Key Specialty Construction.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Helicobacter pylori (Hp) infection is associated with gastrointestinal and systemic disorders in children. This study compared the effects of triple versus quadruple antibiotic therapies on gut microbiota in children with Hp infection. Methods and results Thirty pediatric patients with Hp infection were recruited and randomized into triple or quadruple therapy groups for eradication treatment. Fecal samples were collected before treatment, 2 weeks and 6 weeks post-treatment, followed by 16S rDNA gene sequencing. Baseline gut microbiota showed no significant differences between groups. Triple therapy caused significant disruptions in α-diversity, β-diversity, microbial composition, and metabolic pathways, while quadruple therapy resulted in minimal changes. Post-treatment, quadruple therapy exhibited higher α-diversity, distinct β-diversity, and greater abundance of butyrate-producing bacteria compared to triple therapy. Metabolic pathway analysis also revealed significant differences between the two therapies.

Conclusions

Triple therapy significantly disrupted gut microbiota balance, whereas quadruple therapy had a milder impact in Hp-infected children, preserving microbial diversity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriGastrointestinal MicrobiomeAnti-Bacterial AgentsHumansChildFemaleMaleDrug Therapy, CombinationFecesChild, PreschoolRNA, Ribosomal, 16SAdolescent

Stichwörter der Autor:innen

Helicobacter pylorigut microbiotaquadruple therapiestriple therapies

Substanzen

Anti-Bacterial AgentsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of gastroenterology, Children's Hospital of Fudan University (Xiamen Branch), Xiamen Children's Hospital, Xiamen 361006, China.

Förderung

  • Xiamen medical and health guidance
  • Xiamen Children's Hospital Gastroenterology Clinical Key Specialty Construction

Zitieren

APA

Wang, M., Su, Y., Wang, X., Li, J., Chen, J., & Chen, J. (2025). Triple therapy disrupts gut microbiota more severely than quadruple therapy in children with Helicobacter pylori infection. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxaf133

Vancouver

Wang M, Su Y, Wang X, Li J, Chen J, Chen J. Triple therapy disrupts gut microbiota more severely than quadruple therapy in children with Helicobacter pylori infection. Journal of Applied Microbiology. 2025. doi:10.1093/jambio/lxaf133

BibTeX
@article{Wang2025,
  author = {Wang, Mei and Su, Ying and Wang, Xiaodong and Li, Jialing and Chen, Junhong and Chen, Jingfang},
  title = {Triple therapy disrupts gut microbiota more severely than quadruple therapy in children with Helicobacter pylori infection},
  journal = {Journal of Applied Microbiology},
  year = {2025},
  doi = {10.1093/jambio/lxaf133}
}
Kostenlos starten →